Sherief Abd-Elsalam
Tanta, Egypt
Location status: Recruiting
Location contact
Sherief Abd-Elsalam
CONTACT
Recruiting
NCT Number: NCT03965988
Docosahexaenoic Acid on Breath Holding Spells in Children
DHA on Breath Holding Spells
Recruiting
Interested in participating?
Request InfoKey information
Conditions
Age range
1 month–5 year
Sex eligibility
All sexes
Study type
Interventional
Phase
Phase 3
Primary location
About this study
Effect of DHA on Breath Holding Spells
Who can participate
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
- Children with newly diagnosed sprlls
Exclusion criteria
Other treatment as iron and piracetam
Treatment and study plan
DHA
DrugDocosahexaenoic acid
Other names: Docosahexaenoic acid
Placebo
DrugPlacebo
Other names: Placebo oral tablet
Primary outcomes
-
Frequency of the spells
Time frame: 6 months
Number of attacks
Study contacts
Contact information is provided by the study sponsor or research team.
Sponsors and collaborators
Lead sponsor
Sherief Abd-Elsalam
Other
Registry information
Official study title
Effect of Docosahexaenoic Acid on Breath Holding Spells in Children: A Randomized Controlled Trial
Important dates
- Study start
- 2018
- Primary completion
- 2028
- Study completion
- 2028
- First posted
- May 29, 2019
- Registry last updated
- May 29, 2019
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.